CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Erytech Pharma SA Company Snapshot
Erytech Pharma SA operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Erytech Pharma SA with three other pharmaceutical manufacturers in Europe: Nuevolution AB (publ) of Sweden (2015 sales of 29.73 million Swedish Kronor [US$3.35 million] ), Co Don AG of Germany (5.09 million Euro [US$5.45 million] of which 100% was Product sales), and Byotrol PLC which is based in the United Kingdom (£3.25 million [US$4.03 million] of which 62% was Professional).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Erytech Pharma SA
  Stock Performance Chart for Erytech Pharma SA
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 14.85
(Figures in Euro)
1 Week -5.1%   13 Weeks 17.3%  
4 Weeks -9.8%   52 Weeks -30.0%  
 
Erytech Pharma SA Key Data:
  Ticker: ERYP Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 2,929,000
(Year Ending Jan 2016).
Employees: 55
  Currency: Euro Market Cap: 117,643,348
  Fiscal Yr Ends: December Shares Outstanding: 7,922,111
  Share Type: Actions Ordinaires Closely Held Shares: 669,204
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.